Table 2.

Studies reporting dMMR/MSI prevalence in PACC

Ref	Number of patients analyzed for MSI	Proportion of MSI-H
Abraham et al. (2002)	13	7%
Liu et al. (2014)	36	14%
Bergmann et al. (2014)	42	4.8
Florou et al. (2023)	51	2.1
Sakakida et al. (2023)	44	2.6